CLINICAL TRIALS PROFILE FOR DRIZALMA SPRINKLE
✉ Email this page to a colleague
All Clinical Trials for DRIZALMA SPRINKLE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05611749 ↗ | Duloxetine Impact on Postoperative Pain Control and Outcomes | Not yet recruiting | Scripps Health | Phase 2 | 2022-11-15 | 1. Evaluate differences between patients taking Duloxetine or placebo following lateral lumbar interbody fusion for postoperative narcotic consumption. 2. Evaluate differences between patients taking Duloxetine or placebo following lateral lumbar interbody fusion for postoperative pain, function, and quality of life. 3. Evaluate the correlation between preoperative screening tests (measuring pain centralization, anxiety, depression, and overall function) and patients' response to treatment (reduction in pain, anxiety, or depression and improvement in function). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DRIZALMA SPRINKLE
Condition Name
Clinical Trial Progress for DRIZALMA SPRINKLE
Clinical Trial Phase
Clinical Trial Sponsors for DRIZALMA SPRINKLE
Sponsor Name